Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 236 of 459 found articles
 
 
  274P 5-FU+Nal-IRI vs FOLFOX/XELOX as second-line treatment for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) after gemcitabine and nab-paclitaxel (GemNab): A propensity score-matched analysis
 
 
Title: 274P 5-FU+Nal-IRI vs FOLFOX/XELOX as second-line treatment for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) after gemcitabine and nab-paclitaxel (GemNab): A propensity score-matched analysis
Author: Trovato, G.
Rossini, D.
Su, Y-Y.
Shan, Y-S.
Chiang, N-J.
Chou, W-C.
BagalĂ , C.
Bensi, M.
Niger, M.
Marchesi, S.
Garattini, S.K.
Michelotti, A.
Pretta, A.
Scartozzi, M.
Vivaldi, C.
Bartalini, L.
Procaccio, L.
Chen, L-T.
Tortora, G.
Salvatore, L.
Appeared in: Annals of oncology
Paging: Volume 36 () nr. S1 pages S108
Year: 2025
Contents:
Publisher: Published by Elsevier B.V.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 236 of 459 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands